CVE:SCYB

Scythian Biosciences - SCYB Stock Forecast, Price & News

C$3.49

-0.22 (-5.93%)

(As of 07/25/2018)

Add

Compare

Today's Range: C$3.46
▼
C$3.77
50-Day Range: C$3.49
▼
C$3.49
52-Week Range: C$1.01
▼
C$8.61

Volume: 703,164 shs
Average Volume: 231,491 shs
Market Capitalization: C$102.38 million

P/E Ratio: N/A
Dividend Yield: N/A
Price Target: N/A

About Scythian Biosciences

Scythian Biosciences Corp. engages in the research and development of cannabinoid-based combination drug therapies for the treatment of concussions and traumatic brain injury. It also develops drug candidates for the treatment of gastro-intestinal inflammatory issues. The company is headquartered in Toronto, Canada.

Receive SCYB Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Scythian Biosciences and its competitors with MarketBeat's FREE daily newsletter.

SCYB Stock News Headlines

March 18, 2023 | thestreet.com

Ventrus Biosciences (VTUS) Stock Surges Today

January 5, 2023 | finance.yahoo.com

Scale Biosciences (ScaleBio) Introduces New Disruptive Single-Cell Profiling and Analysis Solutions, Sets New Standards

March 20, 2023 | Behind the Markets (Ad)

Buy THIS stock before Taiwan is attacked

... If the United States goes to war with another nuclear armed superpower, this could have a devastating impact on your retirement portfolio. Now, even Taiwan's own foreign minister is saying that China is on the cusp of a full scale invasion. But the good news is, if China invades Taiwan, there is a way to protect yourself.

June 3, 2022 | baystreet.ca

Canadian Jobs to be Presented Next Friday

April 22, 2020 | www.bloomberg.com

Scythian Invests in PRØHBTD, a Leading Global Cannabis Media Platform

March 15, 2020 | www.bloomberg.com

Scythian Biosciences Appoints Brady Cobb as CEO

February 11, 2020 | www.bloomberg.com

Scythian Biosciences Announces Aphria as Lead Investor in $20 Million Financing

October 31, 2019 | www.bloomberg.com

Scythian Biosciences Appoints Gabriel Meneses as Vice President of Latin America and Caribbean

See More Headlines

30 days | 90 days | 365 days | Advanced Chart

Receive SCYB Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Scythian Biosciences and its competitors with MarketBeat's FREE daily newsletter.

Industry, Sector and Symbol

Stock Exchange: CVE
Industry: Biotechnology
Sub-Industry: N/A
Sector: Medical
Current Symbol: CVE:SCYB
CUSIP: N/A
CIK: N/A
Web: scythianbio.com
Phone: +1-416-3669192
Fax: N/A
Employees: N/A
Year Founded: N/A

Profitability

EPS (Most Recent Fiscal Year): N/A
Trailing P/E Ratio: N/A
Forward P/E Ratio: N/A
P/E Growth: N/A
Net Income: N/A
Net Margins: N/A
Pretax Margin: N/A
Return on Equity: N/A
Return on Assets: N/A

Debt

Debt-to-Equity Ratio: N/A
Current Ratio: N/A
Quick Ratio: N/A

Sales & Book Value

Annual Sales: N/A
Price / Sales: N/A
Cash Flow: N/A
Price / Cash Flow: N/A
Book Value: N/A
Price / Book: N/A

Miscellaneous

Outstanding Shares: 29,334,000
Free Float: N/A
Market Cap: C$102.38 million
Optionable: Not Optionable
Beta: N/A

Key Executives

Mr. Rob Reid
CEO & Director

Mr. Jonathan James Held (Age 32)
Chief Financial Officer

Mr. Maghsoud Dariani (Age 65)
Chief Scientific Officer

Prof. Michael Barnes
Chief Medical Officer

Key Competitors

View All Competitors

SCYB Stock - Frequently Asked Questions

How have SCYB shares performed in 2023?: Scythian Biosciences' stock was trading at C$3.49 at the beginning of the year. Since then, SCYB shares have increased by 0.0% and is now trading at C$3.49.
View the best growth stocks for 2023 here.
What other stocks do shareholders of Scythian Biosciences own?: Based on aggregate information from My MarketBeat watchlists, some companies that other Scythian Biosciences investors own include Cross Timbers Royalty Trust (CRT), Archer-Daniels-Midland (ADM), InfraCap MLP ETF (AMZA), Alliance Resource Partners (ARLP), Brigham Minerals (MNRL), Organigram (OGI), Roku (ROKU), Scythian Biosciences (SCCYF) and Abbott Laboratories (ABT).
What is Scythian Biosciences' stock symbol?: Scythian Biosciences trades on the Canadian Venture Exchange (CVE) under the ticker symbol "SCYB."

How do I buy shares of Scythian Biosciences?: Shares of SCYB stock and other Canadian stocks can be purchased through an online brokerage account. Popular online brokerages with access to the Canadian stock market include BMO InvestorLine, CIBC Investor's Edge, Desjardins Online Brokerage, HSBC InvestDirect, Laurentian Bank Discount Brokerage, National Bank Direct Brokerage, Qtrade Investor, Questrade, RBC Direct Investing, Scotia iTrade, TD Direct Investing, and Virtual Brokers.
Compare Top Brokerages Here.
What is Scythian Biosciences' stock price today?: One share of SCYB stock can currently be purchased for approximately C$3.49.
How much money does Scythian Biosciences make?: Scythian Biosciences (CVE:SCYB) has a market capitalization of C$102.38 million.
How can I contact Scythian Biosciences?: Scythian Biosciences' mailing address is 366 Bay St Suite 200, TORONTO, ON M5H 4B2, Canada. The official website for the company is scythianbio.com. The company can be reached via phone at +1-416-3669192.

This page (CVE:SCYB) was last updated on 3/20/2023 by MarketBeat.com Staff

Get 30 Days of MarketBeat All Access Free

Best-in-Class Portfolio Monitoring
View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.
Stock Ideas and Recommendations
Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report.
Advanced Stock Screeners and Research Tools
Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis.

Start Your 30-Day Free Trial